Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

QIAGEN Total Liabilities 2010-2024 | QGEN

QIAGEN total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • QIAGEN total liabilities for the quarter ending December 31, 2024 were $2.122B, a 8.02% decline year-over-year.
  • QIAGEN total liabilities for 2024 were $2.122B, a 8.02% decline from 2023.
  • QIAGEN total liabilities for 2023 were $2.307B, a 18.21% decline from 2022.
  • QIAGEN total liabilities for 2022 were $2.821B, a 7.52% decline from 2021.
  
QIAGEN Annual Total Liabilities
(Millions of US $)
2024 $2,122
2023 $2,307
2022 $2,821
2021 $3,050
2020 $3,072
2019 $2,699
2018 $3,113
2017 $2,498
2016 $1,701
2015 $1,611
2014 $1,796
2013 $1,365
2012 $1,363
2011 $1,172
2010 $1,438
2009 $1,505
QIAGEN Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $2,122
2024-09-30 $2,740
2024-06-30 $2,179
2024-03-31 $2,206
2023-12-31 $2,307
2023-09-30 $2,213
2023-06-30 $2,724
2023-03-31 $2,718
2022-12-31 $2,821
2022-09-30 $3,189
2022-06-30 $2,871
2022-03-31 $2,944
2021-12-31 $3,050
2021-09-30 $3,030
2021-06-30 $2,930
2021-03-31 $2,913
2020-12-31 $3,072
2020-09-30 $3,060
2020-06-30 $2,674
2020-03-31 $2,689
2019-12-31 $2,699
2019-09-30 $2,675
2019-06-30 $2,750
2019-03-31 $2,814
2018-12-31 $3,113
2018-09-30 $2,772
2018-06-30 $2,785
2018-03-31 $2,525
2017-12-31 $2,498
2017-09-30 $2,530
2017-06-30 $2,051
2017-03-31 $1,638
2016-12-31 $1,701
2016-09-30 $1,662
2016-06-30 $1,492
2016-03-31 $1,495
2015-12-31 $1,611
2015-09-30 $1,639
2015-06-30 $1,594
2015-03-31 $1,691
2014-12-31 $1,796
2014-09-30 $1,748
2014-06-30 $1,809
2014-03-31 $1,754
2013-12-31 $1,365
2013-09-30 $1,379
2013-06-30 $1,381
2013-03-31 $1,343
2012-12-31 $1,363
2012-09-30 $1,245
2012-06-30 $1,235
2012-03-31 $1,163
2011-12-31 $1,172
2011-09-30 $1,364
2011-06-30 $1,404
2011-03-31 $1,422
2010-12-31 $1,438
2010-09-30 $1,460
2010-06-30 $1,433
2010-03-31 $1,469
2009-12-31 $1,505
2009-09-30 $1,526
2009-06-30 $1,436
2009-03-31 $1,370
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.049B $1.978B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $209.613B 16.44
Amgen (AMGN) United States $149.085B 13.99
Gilead Sciences (GILD) United States $130.169B 22.68
Vertex Pharmaceuticals (VRTX) United States $125.596B 0.00
Bristol Myers Squibb (BMY) United States $100.171B 43.18
CSL (CSLLY) Australia $74.317B 0.00
GSK (GSK) United Kingdom $74.132B 8.89
Regeneron Pharmaceuticals (REGN) United States $61.567B 14.19
Argenex SE (ARGX) Netherlands $36.226B 250.50
Alnylam Pharmaceuticals (ALNY) United States $30.513B 0.00
BioNTech SE (BNTX) Germany $23.700B 0.00
BeiGene (ONC) Cayman Islands $22.837B 0.00
Biogen (BIIB) United States $17.362B 7.20
Genmab (GMAB) Denmark $13.262B 16.16
Genmab (GNMSF) Denmark $13.255B 13.66
Insmed (INSM) United States $13.209B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.290B 21.75
Illumina (ILMN) United States $11.268B 29.06
Incyte (INCY) United States $11.265B 342.41
Ascendis Pharma (ASND) Denmark $10.063B 0.00
Exelixis (EXEL) United States $9.973B 20.68
Swedish Orphan Biovitrum (BIOVF) Sweden $9.612B 24.55
Moderna (MRNA) United States $9.555B 0.00
Exact Sciences (EXAS) United States $7.724B 0.00
Bio-Techne Corp (TECH) United States $7.604B 29.15
Repligen (RGEN) United States $7.299B 87.84
Halozyme Therapeutics (HALO) United States $7.263B 15.00
Roivant Sciences (ROIV) United Kingdom $7.243B 0.00
Revolution Medicines (RVMD) United States $6.834B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.311B 21.85
Jazz Pharmaceuticals (JAZZ) Ireland $6.242B 5.64
Legend Biotech (LEGN) United States $6.024B 0.00
TG Therapeutics (TGTX) United States $6.019B 273.71
Telix Pharmaceuticals (TLX) Australia $5.646B 0.00
Guardant Health (GH) United States $5.550B 0.00
Blueprint Medicines (BPMC) United States $5.412B 0.00
Sarepta Therapeutics (SRPT) United States $5.219B 24.56
Nuvalent (NUVL) United States $5.129B 0.00
Axsome Therapeutics (AXSM) United States $5.094B 0.00
ADMA Biologics Inc (ADMA) United States $5.037B 42.62
Verona Pharma American Depositary Share (VRNA) United Kingdom $5.007B 0.00
Krystal Biotech (KRYS) United States $4.871B 50.77
Cytokinetics (CYTK) United States $4.706B 0.00
Zealand Pharma (ZLDPF) Denmark $4.604B 0.00
Alkermes (ALKS) Ireland $4.451B 11.16
Vaxcyte (PCVX) United States $3.947B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.903B 0.00
PTC Therapeutics (PTCT) United States $3.738B 0.00
Arcellx (ACLX) United States $3.408B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.351B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.262B 0.00
Avidity Biosciences (RNA) United States $3.205B 0.00
Zai Lab (ZLAB) China $3.162B 0.00
Akero Therapeutics (AKRO) United States $2.996B 0.00
Merus (MRUS) Netherlands $2.975B 0.00
Scholar Rock Holding (SRRK) United States $2.917B 0.00
SpringWorks Therapeutics (SWTX) United States $2.842B 0.00
Protagonist Therapeutics (PTGX) United States $2.841B 11.02
Viking Therapeutics (VKTX) United States $2.688B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.687B 0.00
Immunovant (IMVT) United States $2.573B 0.00
Alvotech (ALVO) Luxembourg $2.499B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.457B 21.99
MoonLake Immunotherapeutics (MLTX) Switzerland $2.453B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.399B 0.00
Certara (CERT) United States $2.285B 48.79
Apellis Pharmaceuticals (APLS) United States $2.284B 0.00
Twist Bioscience (TWST) United States $2.195B 0.00
ImmunityBio (IBRX) United States $2.108B 0.00
Amicus Therapeutics (FOLD) United States $2.098B 113.83
Biohaven (BHVN) United States $2.079B 0.00
Vericel (VCEL) United States $2.067B 229.06
Metsera (MTSR) United States $2.056B 0.00
Ligand Pharmaceuticals (LGND) United States $2.021B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.934B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.890B 0.00
Denali Therapeutics (DNLI) United States $1.850B 0.00
Belite Bio (BLTE) United States $1.796B 0.00
Bavarian Nordic (BVNRY) Denmark $1.793B 12.63
Janux Therapeutics (JANX) United States $1.755B 0.00
NovoCure (NVCR) Jersey $1.712B 0.00
Beam Therapeutics (BEAM) United States $1.696B 0.00
Kymera Therapeutics (KYMR) United States $1.687B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.632B 11.34
Ascentage Pharma Group - (AAPG) China $1.630B 0.00
Agios Pharmaceuticals (AGIO) United States $1.585B 0.00
CG Oncology (CGON) United States $1.573B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.543B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.543B 0.00
ANI Pharmaceuticals (ANIP) United States $1.507B 17.05
IDEAYA Biosciences (IDYA) United States $1.495B 0.00
Apogee Therapeutics (APGE) United States $1.491B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.468B 0.00
Disc Medicine (IRON) United States $1.458B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.421B 0.00
Edgewise Therapeutics (EWTX) United States $1.409B 0.00
MannKind (MNKD) United States $1.379B 28.38
Mesoblast (MESO) Australia $1.362B 0.00
Vera Therapeutics (VERA) United States $1.357B 0.00
Travere Therapeutics (TVTX) United States $1.324B 0.00
Dynavax Technologies (DVAX) United States $1.279B 57.28
Structure Therapeutics (GPCR) United States $1.248B 0.00
NeoGenomics (NEO) United States $1.229B 0.00
Celldex Therapeutics (CLDX) United States $1.215B 0.00
Liquidia Technologies (LQDA) United States $1.170B 0.00
Pacira BioSciences (PCRX) United States $1.141B 10.72
Adaptive Biotechnologies (ADPT) United States $1.089B 0.00
Viridian Therapeutics (VRDN) United States $1.070B 0.00
BGM Group (BGM) China $1.070B 0.00
Iovance Biotherapeutics (IOVA) United States $1.003B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.993B 0.00
MiMedx (MDXG) United States $0.984B 23.03
Novavax (NVAX) United States $0.965B 0.00
GRAIL (GRAL) United States $0.953B 0.00
Anbio Biotechnology (NNNN) Germany $0.951B 0.00
WAVE Life Sciences (WVE) Singapore $0.909B 0.00
89BIO (ETNB) United States $0.885B 0.00
Mineralys Therapeutics (MLYS) United States $0.866B 0.00
Gyre Therapeutics (GYRE) United States $0.831B 111.00
Arcus Biosciences (RCUS) United States $0.828B 0.00
Geron (GERN) United States $0.809B 0.00
Zymeworks (ZYME) United States $0.802B 0.00
Oculis Holding AG (OCS) Switzerland $0.798B 0.00
Nurix Therapeutics (NRIX) United States $0.781B 0.00
Spyre Therapeutics (SYRE) United States $0.764B 0.00
Anavex Life Sciences (AVXL) United States $0.761B 0.00
Vir Biotechnology (VIR) United States $0.754B 0.00
Intellia Therapeutics (NTLA) United States $0.748B 0.00
Pharvaris (PHVS) Netherlands $0.732B 0.00
AbCellera Biologics (ABCL) Canada $0.721B 0.00
Myriad Genetics (MYGN) United States $0.704B 0.00
UniQure (QURE) Netherlands $0.703B 0.00
CureVac (CVAC) Germany $0.700B 3.80
Day One Biopharmaceuticals (DAWN) United States $0.693B 0.00
Immunome (IMNM) United States $0.688B 0.00
Praxis Precision Medicines (PRAX) United States $0.681B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.675B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.672B 0.00
Nuvation Bio (NUVB) United States $0.667B 0.00
Bicara Therapeutics (BCAX) United States $0.663B 0.00
LENZ Therapeutics (LENZ) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
AnaptysBio (ANAB) United States $0.630B 0.00
Dianthus Therapeutics (DNTH) United States $0.626B 0.00
Castle Biosciences (CSTL) United States $0.620B 34.69
ArriVent BioPharma (AVBP) United States $0.617B 0.00
Replimune (REPL) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.604B 0.00
Arbutus Biopharma (ABUS) United States $0.603B 0.00
Arvinas (ARVN) United States $0.591B 0.00
Trevi Therapeutics (TRVI) United States $0.587B 0.00
Keros Therapeutics (KROS) United States $0.571B 0.00
Pharming Group (PHAR) Netherlands $0.550B 0.00
Niagen Bioscience (NAGE) United States $0.526B 169.00
Opthea (OPT) Australia $0.525B 0.00
Immatics (IMTX) Germany $0.518B 30.43
Bicycle Therapeutics (BCYC) United Kingdom $0.511B 0.00
CorMedix Inc (CRMD) United States $0.500B 0.00
Cogent Biosciences (COGT) United States $0.498B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Northwest Biotherapeutics (NWBO) United States $0.493B 0.00
Sionna Therapeutics (SION) United States $0.488B 0.00
Fortrea Holdings (FTRE) United States $0.477B 15.56
Kura Oncology (KURA) United States $0.477B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.474B 0.00
Tyra Biosciences (TYRA) United States $0.474B 0.00
GH Research (GHRS) Ireland $0.473B 0.00
Upstream Bio (UPB) United States $0.471B 0.00
Cytek Biosciences (CTKB) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.462B 0.00
Sage Therapeutics (SAGE) United States $0.457B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.456B 0.00
Urogen Pharma (URGN) United States $0.446B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.436B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.435B 0.00
MeiraGTx Holdings (MGTX) United States $0.427B 0.00
Stoke Therapeutics (STOK) United States $0.416B 0.00
Precigen (PGEN) United States $0.409B 0.00
Abivax SA (ABVX) France $0.406B 0.00
PureTech Health (PRTC) United States $0.402B 0.00
Absci (ABSI) United States $0.394B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.390B 0.00
Celcuity (CELC) United States $0.387B 0.00
Eton Pharmaceuticals (ETON) United States $0.385B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.381B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.379B 0.00
Kamada (KMDA) Israel $0.374B 25.00
Zenas BioPharma (ZBIO) United States $0.373B 0.00
Sana Biotechnology (SANA) United States $0.371B 0.00
Rapport Therapeutics (RAPP) United States $0.370B 0.00
Maze Therapeutics (MAZE) United States $0.368B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.366B 0.00
Oric Pharmaceuticals (ORIC) United States $0.339B 0.00
Checkpoint Therapeutics (CKPT) United States $0.338B 0.00
Erasca (ERAS) United States $0.329B 0.00
Benitec Biopharma (BNTC) United States $0.322B 0.00
Tectonic Therapeutic (TECX) United States $0.318B 0.00
Allogene Therapeutics (ALLO) United States $0.315B 0.00
Alpha Teknova (TKNO) United States $0.308B 0.00
Entrada Therapeutics (TRDA) United States $0.306B 4.26
Olema Pharmaceuticals (OLMA) United States $0.302B 0.00
REGENXBIO (RGNX) United States $0.298B 0.00
Verastem (VSTM) United States $0.296B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.286B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.281B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.280B 0.00
MaxCyte (MXCT) United States $0.277B 0.00
ATyr Pharma (ATYR) United States $0.275B 0.00
Cartesian Therapeutics (RNAC) United States $0.272B 0.00
Aura Biosciences (AURA) United States $0.269B 0.00
Palvella Therapeutics (PVLA) United States $0.268B 0.00
Septerna (SEPN) United States $0.262B 0.00
2seventy Bio (TSVT) United States $0.261B 0.00
Humacyte (HUMA) United States $0.261B 0.00
MBX Biosciences (MBX) United States $0.255B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
XOMA Royalty (XOMA) United States $0.253B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.253B 0.00
Emergent Biosolutions (EBS) United States $0.251B 0.00
ITeos Therapeutics (ITOS) United States $0.249B 0.00
Monopar Therapeutics (MNPR) United States $0.242B 0.00
Compass Therapeutics (CMPX) United States $0.242B 0.00
Lifecore Biomedical (LFCR) United States $0.237B 0.00
Abeona Therapeutics (ABEO) United States $0.236B 0.00
Alumis (ALMS) United States $0.236B 0.00
Bright Minds Biosciences (DRUG) United States $0.233B 0.00
Third Harmonic Bio (THRD) United States $0.233B 0.00
Astria Therapeutics (ATXS) United States $0.228B 0.00
Prima BioMed (IMMP) Australia $0.225B 0.00
ACELYRIN, INC (SLRN) United States $0.222B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.221B 0.00
Candel Therapeutics (CADL) United States $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.214B 0.00
Adocia (ADOCY) France $0.213B 0.00
Cidara Therapeutics (CDTX) United States $0.213B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.212B 0.00
Foghorn Therapeutics (FHTX) United States $0.211B 0.00
Terns Pharmaceuticals (TERN) United States $0.210B 0.00
Nuvectis Pharma (NVCT) United States $0.207B 0.00
EnGene Holdings (ENGN) Canada $0.204B 0.00
BioStem Technologies (BSEM) $0.203B 8.11
Anika Therapeutics (ANIK) United States $0.199B 0.00
Design Therapeutics (DSGN) United States $0.199B 0.00
Ocugen (OCGN) United States $0.198B 0.00
Solid Biosciences (SLDB) United States $0.198B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Cardiff Oncology (CRDF) United States $0.190B 0.00
Amarin (AMRN) Ireland $0.187B 0.00
TuHURA Biosciences (HURA) United States $0.181B 0.00
Semper Paratus Acquisition (TVGN) United States $0.180B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.179B 0.00
Fulcrum Therapeutics (FULC) United States $0.178B 0.00
Inventiva S.A (IVA) France $0.176B 0.00
GENFIT S.A (GNFT) France $0.175B 0.00
Codexis (CDXS) United States $0.175B 0.00
Voyager Therapeutics (VYGR) United States $0.174B 0.00
Neurogene (NGNE) United States $0.172B 0.00
INmune Bio (INMB) United States $0.168B 0.00
Rezolute (RZLT) United States $0.166B 0.00
Inhibrx Biosciences (INBX) United States $0.166B 0.00
Innate Pharma S.A (IPHA) France $0.165B 0.00
DBV Technologies S.A (DBVT) France $0.164B 0.00
Prime Medicine (PRME) United States $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.160B 0.00
Annexon (ANNX) United States $0.160B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Actuate Therapeutics (ACTU) United States $0.156B 0.00
Aardvark Therapeutics (AARD) United States $0.152B 0.00
DiaMedica Therapeutics (DMAC) United States $0.152B 0.00
Kodiak Sciences (KOD) United States $0.150B 0.00
AC Immune (ACIU) Switzerland $0.149B 0.00
Puma Biotechnology (PBYI) United States $0.142B 4.69
Adherex Technologies (FENC) United States $0.140B 0.00
Tango Therapeutics (TNGX) United States $0.139B 0.00
BioAge Labs (BIOA) United States $0.139B 0.00
Compugen (CGEN) Israel $0.131B 0.00
Coherus BioSciences (CHRS) United States $0.130B 0.00
ScPharmaceuticals (SCPH) United States $0.129B 0.00
Nkarta (NKTX) United States $0.128B 0.00
Fate Therapeutics (FATE) United States $0.127B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.126B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.125B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.120B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.120B 0.00
Contineum Therapeutics (CTNM) United States $0.120B 0.00
Galena Biopharma (SLS) United States $0.119B 0.00
Greenwich LifeSciences (GLSI) United States $0.119B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.118B 0.00
Seer (SEER) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.109B 0.00
Editas Medicine (EDIT) United States $0.107B 0.00
Neumora Therapeutics (NMRA) United States $0.105B 0.00
Rapt Therapeutics (RAPT) United States $0.104B 0.00
Cuprina Holdings (Cayman) (CUPR) $0.104B 0.00
Instil Bio (TIL) United States $0.101B 0.00
Senti Biosciences (SNTI) United States $0.101B 0.00
Nautilus Biotechnology (NAUT) United States $0.096B 0.00
Elutia (ELUT) United States $0.095B 0.00
Immunic (IMUX) United States $0.094B 0.00
BioHarvest Sciences (BHST) Canada $0.093B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.093B 0.00
Alector (ALEC) United States $0.091B 0.00
Genelux (GNLX) United States $0.091B 0.00
EXoZymes (EXOZ) United States $0.091B 0.00
XBiotech (XBIT) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
C4 Therapeutics (CCCC) United States $0.089B 0.00
Coya Therapeutics (COYA) United States $0.088B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.088B 0.00
CervoMed (CRVO) United States $0.085B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
HilleVax (HLVX) United States $0.085B 0.00
Zura Bio (ZURA) United States $0.084B 0.00
Vigil Neuroscience (VIGL) United States $0.084B 0.00
Black Diamond Therapeutics (BDTX) United States $0.082B 0.00
TScan Therapeutics (TCRX) United States $0.081B 0.00
Entera Bio (ENTX) Israel $0.081B 0.00
Vor Biopharma (VOR) $0.081B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
Kyverna Therapeutics (KYTX) United States $0.080B 0.00
Aerovate Therapeutics (AVTE) United States $0.080B 0.00
Ventyx Biosciences (VTYX) United States $0.076B 0.00
Elicio Therapeutics (ELTX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.073B 0.00
Adagene (ADAG) China $0.072B 0.00
InflaRx (IFRX) Germany $0.071B 0.00
MediciNova (MNOV) United States $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
I-Mab (IMAB) United States $0.069B 0.00
Caribou Biosciences (CRBU) United States $0.068B 0.00
Sagimet Biosciences (SGMT) United States $0.068B 0.00
Rani Therapeutics Holdings (RANI) United States $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.066B 0.00
Alpha Cognition (ACOG) Canada $0.066B 0.00
Seres Therapeutics (MCRB) United States $0.065B 0.00
Inovio Pharmaceuticals (INO) United States $0.064B 0.00
Biomea Fusion (BMEA) United States $0.064B 0.00
Adlai Nortye (ANL) Cayman Islands $0.063B 0.00
VTv Therapeutics (VTVT) United States $0.063B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.061B 0.00
Adverum Biotechnologies (ADVM) United States $0.061B 0.00
Alto Neuroscience (ANRO) United States $0.061B 0.00
Invivyd (IVVD) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
ZIVO Bioscience (ZIVO) United States $0.061B 0.00
Jasper Therapeutics (JSPR) United States $0.060B 0.00
Inozyme Pharma (INZY) United States $0.059B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Renovaro (RENB) United States $0.056B 0.00
Cabaletta Bio (CABA) United States $0.056B 0.00
Artiva Biotherapeutics (ARTV) United States $0.055B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.055B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
Akoya Biosciences (AKYA) United States $0.054B 0.00
Medicus Pharma (MDCX) United States $0.054B 0.00
Ikena Oncology (IKNA) United States $0.054B 0.00
Exicure (XCUR) United States $0.053B 0.00
Precision BioSciences (DTIL) United States $0.053B 0.00
BeyondSpring (BYSI) United States $0.053B 0.00
Agenus (AGEN) United States $0.053B 0.00
CytomX Therapeutics (CTMX) United States $0.053B 1.73
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.052B 0.00
Repare Therapeutics (RPTX) Canada $0.051B 0.00
PDS Biotechnology (PDSB) United States $0.049B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.049B 0.00
Oncolytics Biotech (ONCY) Canada $0.048B 0.00
Forte Biosciences (FBRX) United States $0.048B 0.00
Citius Oncology (CTOR) United States $0.048B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.047B 0.00
Applied Therapeutics (APLT) United States $0.047B 0.00
Cue Biopharma (CUE) United States $0.047B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.047B 0.00
Oncobiologics (OTLK) United States $0.046B 0.00
Immuneering (IMRX) United States $0.046B 0.00
Immix Biopharma (IMMX) United States $0.045B 0.00
Fortress Biotech (FBIO) United States $0.045B 0.00
FibroBiologics (FBLG) United States $0.045B 0.00
Skye Bioscience (SKYE) United States $0.044B 0.00
Sutro Biopharma (STRO) United States $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Quince Therapeutics (QNCX) United States $0.044B 0.00
Adicet Bio (ACET) United States $0.043B 0.00
PepGen (PEPG) United States $0.043B 0.00
Spero Therapeutics (SPRO) United States $0.042B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.041B 0.00
Werewolf Therapeutics (HOWL) United States $0.041B 0.00
Connect Biopharma Holdings (CNTB) United States $0.041B 0.00
Bluebird Bio (BLUE) United States $0.041B 0.00
CAMP4 Therapeutics (CAMP) United States $0.040B 0.00
Tenaya Therapeutics (TNYA) United States $0.039B 0.00
Advanced Biomed (ADVB) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.039B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Whitehawk Therapeutics (WHWK) United States $0.039B 0.00
AN2 Therapeutics (ANTX) United States $0.038B 0.00
TELA Bio (TELA) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.037B 0.00
Shattuck Labs (STTK) United States $0.037B 0.00
Celularity (CELU) United States $0.037B 0.00
Dyadic (DYAI) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
Atara Biotherapeutics (ATRA) United States $0.036B 0.00
Kalaris Therapeutics (KLRS) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.034B 0.00
X4 Pharmaceuticals (XFOR) United States $0.033B 0.00
Radiopharm Theranostics - (RADX) Australia $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
Boundless Bio (BOLD) United States $0.032B 0.00
Cadrenal Therapeutics (CVKD) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.030B 0.00
Allakos (ALLK) United States $0.029B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Estrella Immunopharma (ESLA) United States $0.029B 0.00
Aligos Therapeutics (ALGS) United States $0.029B 0.00
Pluri (PLUR) Israel $0.028B 0.00
Intensity Therapeutics (INTS) United States $0.028B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.028B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.028B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.027B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
Cara Therapeutics (TVRD) United States $0.026B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
Clene (CLNN) United States $0.026B 0.00
Dare Bioscience (DARE) United States $0.026B 0.00
Lexaria Bioscience (LEXX) Canada $0.024B 0.00
Cognition Therapeutics (CGTX) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
KALA BIO (KALA) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.022B 0.00
Longeveron (LGVN) United States $0.022B 0.00
Grace Therapeutics (GRCE) Canada $0.021B 0.00
CalciMedica (CALC) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.020B 0.00
Lisata Therapeutics (LSTA) United States $0.019B 0.00
BioAtla (BCAB) United States $0.019B 0.00
Annovis Bio (ANVS) United States $0.017B 0.00
Equillium (EQ) United States $0.017B 0.00
Cingulate (CING) United States $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Enzo Biochem (ENZ) United States $0.016B 0.00
UNITY Biotechnology (UBX) United States $0.016B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
BRIACELL THERAP (BCTX) Canada $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.016B 0.00
Leap Therapeutics (LPTX) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
ABVC BioPharma (ABVC) United States $0.013B 0.00
Bolt Biotherapeutics (BOLT) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
Cocrystal Pharma (COCP) United States $0.013B 0.00
SAB Biotherapeutics (SABS) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
IN8bio (INAB) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
LakeShore Biopharma (LSB) China $0.013B 0.00
Synlogic (SYBX) United States $0.012B 0.00
Moleculin Biotech (MBRX) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Quantum Biopharma (QNTM) Canada $0.012B 0.00
Affimed (AFMD) Germany $0.012B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Curis (CRIS) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Rallybio (RLYB) United States $0.010B 0.00
Hoth Therapeutics (HOTH) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
NextCure (NXTC) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Athira Pharma (ATHA) United States $0.009B 0.00
HOOKIPA Pharma (HOOK) United States $0.009B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Gelteq (GELS) Australia $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Aprea Therapeutics (APRE) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Dogwood Therapeutics (DWTX) United States $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Ocean Biomedical (OCEA) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
MetaVia (MTVA) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.005B 0.00
Evogene (EVGN) Israel $0.005B 0.00
Spruce Biosciences (SPRB) United States $0.005B 0.00
NuCana (NCNA) United Kingdom $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Arcadia Biosciences (RKDA) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Novogen (KZIA) Australia $0.003B 0.00
Galecto (GLTO) Denmark $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Organovo Holdings (ONVO) United States $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Evaxion Biotech (EVAX) Denmark $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.002B 0.00
Eyenovia (EYEN) United States $0.002B 0.00
Polyrizon (PLRZ) Israel $0.001B 0.00
Vincerx Pharma (VINC) United States $0.001B 0.00
NAYA Biosciences (NAYA) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.001B 0.00
Windtree Therapeutics (WINT) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Capstone Therapeutics (CAPS) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00